Merck Sells DoD Financed Covid Pill Molnupiravir At 40 Times The Cost Price

According to a report, the US Department of Defense financed COVID pill Molnupiravir is being sold by Merck at 40 times the actual cost price.

A 5 day course of molnupiravir, costs $17.74 to produce, according to a report (read below) published by The Intercept issued last week by drug pricing experts at the Harvard School of Public Health and King’s College Hospital in London.

However, Merck is charging the U.S. government $712 for the same amount of medicine, or 40 times the price.
...

Subscribe to view this content.

Explore exclusive GGI coverage of Donald Trump’s assassination attempt.

 
Do you have a tip or sensitive material to share with GGI? Are you a journalist, researcher or independent blogger and want to write for us? You can reach us at [email protected].